| Prev Close | 14.90 |
| Day Low/High | 14.17 / 15.01 |
| 52 Wk Low/High | 3.52 / 21.93 |
Aurinia Pharmaceuticals Inc. (AUPH)
14.82
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 126.25B |
| Market Cap | 1.88B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Hottest Sectors Start to Cool Off
Precious metals are an exception but electric vehicles and SPACs have lost their luster.
The Price Action Is Still Holding Up Relatively Well
There are opportunities but you better be selective and move fast.
4 Biotechnology Stocks I'm Buying on Weakness
It isn't just the bears that would welcome a pullback in this market.
6 Biotech Stocks I'm Looking to Buy as Hot Momentum Cools
My main focus right now is on stronger defense.
Here's How I'm Positioned and What I'm Holding
I see no reason to put much money into longer-term positions right now, but here are some of my biggest positions.
Update on My Top Picks for 2020, and a Look at Disney
I continue to follow the 6 names and believe several of them will recover well.
Small-Caps Are Finally Seeing Some Bottom Fishing
I believe this is just bounce action at this point and not a bottom, but I'm playing it.
How Am I Doing? An Update on My Top 6 Stock Picks for 2020
I've previously discussed why these six stocks are my top picks for 2020. I will periodically provide updates and discuss my strategy for trading them.
Trading Notes on 21 Stocks I Currently Own
Here are my takes on stocks in biotech and other companies I own right now.
My 5 Top Stock Picks for 2020: How I'm Trading Them Now
Given broader market weakness, this is a good time to take a look at these names and develop strategies.
The Dow Touches 29,000 and Sellers Step In
It is highly unlikely that the indices are going to roll over and go straight down from here.
My Top Stock Pick for 2020 Is a Super Strong Finisher From 2019
There will be other stocks that do better, but this one has the potential of a big gain but with limited downside.
No Rush to Add New Exposure Right Now
My main focus is ending the year with accounts at highs and having plenty of cash on hand.
Trade With Your Cup Half Full
I learned from Jim Cramer long ago to focus on what can go right if you want to ride the momentum of stocks.
The Heart of Effective Trading Is Finding a Steady Supply of Fresh Ideas
If you stick with the same old names every day, then you are an investor and not a trader; outsize gains require outsize efforts.
Stocks With This Characteristic Are Very Rare - But We Found One
Aurinia Pharmaceuticals has 'lost its gravity.'
There Continues to Be Some Pockets of Market Strength
The trading action is not bad if you are selective and have short time frames.
Jobs Numbers Jolt Both Bears and Bulls
The recovery has now occurred so fast that the bulls did not act quickly enough and are again struggling with Fear of Missing Out.
Weakness After Protracted Upside Move Causes Discomfort
Some traders seem unsettled by a bit of downside volatility after not experiencing much of it of late.
The Technical Patterns Paint a Positive Picture
A three-day pullback was exactly what this market needed at exactly the right time.
This Poor Market Action Is Creating a Whole New Crop of Opportunities
I tend to focus more on individual stocks and my job right now is to develop a list of names that I want to follow more closely as this action develops.
Exhaustion? Not Much Evidence Just Yet
The market may need some rest and consolidation, but that doesn't mean it will produce a lot of downside.
Is the Market Half Full or Half Empty? Depends on How You See It
Whether you see the indexes trading flat on Monday afternoon as good or bad depends on your outlook.
Overconfident Bears Have Missed Out on Great Opportunities
I am carrying a large cash balance -- but not because I'm bearish.
Here Are 6 Small-Caps on My Radar
I'm optimistic that we will see some better stock picking action if the breakout holds and momentum continues.
5 Favorites for Biotech Stock Buyers
For those with a long-term horizon, here are some top picks.
An Example of How I Stalk a Trade
With Aurinia Pharmaceuticals, the key is to be patient and to buy incrementally.
The Fed Decision Will Be a Market Mover No Matter What
Computer algorithms will trigger volatility even if there is no surprise news.
